Johnson and Johnson announced strong earnings results with revenue coming in at $20.5 billion. They raised their full year guidance but also indicated that generic drugs would impact the company’s earnings.
Here are some further trades done in Johnson and Johnson Stock (JNJ) after earnings were released today.
The rest of this Johnson and Johnson Stock (JNJ) trade article is for FullyInformed Members.
Johnson and Johnson Stock (JNJ) Trades After Earnings Announcement – Jul 16 2019